- Home
- UHT vs ETON Comparison
UHT vs ETON Comparison
Compare UHT & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHT | ETON |
|---|---|---|
| Founded | 1986 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 593.0M | 510.1M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UHT | ETON |
|---|---|---|
| Price | $40.88 | $23.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 48.4K | ★ 337.4K |
| Earning Date | 04-27-2026 | 03-19-2026 |
| Dividend Yield | ★ 7.37% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $99,190,000.00 | $79,950,000.00 |
| Revenue This Year | $2.12 | $34.30 |
| Revenue Next Year | $2.94 | $36.43 |
| P/E Ratio | $31.95 | ★ N/A |
| Revenue Growth | 0.18 | ★ 104.94 |
| 52 Week Low | $35.26 | $11.09 |
| 52 Week High | $44.70 | $23.00 |
Technical Indicators
Market Signals| Indicator | UHT | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 36.55 | 83.14 |
| Support Level | $38.72 | $16.23 |
| Resistance Level | $41.64 | N/A |
| Average True Range (ATR) | 1.12 | 1.12 |
| MACD | -0.37 | 0.51 |
| Stochastic Oscillator | 27.59 | 97.47 |
Price Performance
Historical ComparisonAbout UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.